Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

R-FCM protocol MeSH Supplementary Concept Data 2025


MeSH Supplementary
R-FCM protocol
Unique ID
C518738
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C518738
Registry Numbers
0
Previous Indexing
Antibodies, Monoclonal (2007-2010)
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Mitoxantrone
Vidarabine / analogs & derivatives
*Rituximab
Frequency
4
Note
chemotherapy protocol consisting of rituximab, fludarabine, cyclophosphamide, and mitoxanthrone for treatment of mantle cell lymphoma
Source
Leukemia 2007 Mar;21(3):524-8
Date of Entry
2007/04/11
Revision Date
2021/08/09
R-FCM protocol Preferred
page delivered in 0.004s